Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?

M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur and Colin D. Hall the AIDS Clinical Trials Group, 243 Team
American Journal of Neuroradiology November 1999, 20 (10) 1896-1906;
M. Judith Donovan Post
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantin Yiannoutsos
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Simpson
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Booss
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B. Clifford
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Cohen
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin C. McArthur
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin D. Hall
aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. ↵
    Hall CD, Dafini U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998;338:1345-1351
    CrossRefPubMedWeb of Science
  2. ↵
    Berger JR, Kaszovitz B, Post MJD, Dickinson G, Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987;107:78-87
    CrossRefPubMedWeb of Science
  3. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J, Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985;17:344-349
    CrossRefPubMedWeb of Science
  4. Petito CK, Cho ES, Lemann W, Navia BA, Price RW, Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 1986;45:635-646
    CrossRef
  5. ↵
    Levy RM, Bredesen DE, Rosenblum ML, Neurological manifestations of the acquired immune deficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475-495
    CrossRefPubMedWeb of Science
  6. Berger JR, Moskovitz L, Fischl M, Kelley RE, The neurologic complications of AIDS: frequently the initial manifestation. Neurology 1984;34(Suppl 1):134-135
    FREE Full Text
  7. ↵
    Karahalios D, Breit R, Dal Conto MC, Levy RM, Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:1030-1038
  8. ↵
    Sweeney BJ, Miller RF, Harrison MJG, Progressive multifocal leukoencephalopathy. Br J Hosp Med 1993;50:187-192
    PubMed
  9. Richardson EP, Jr, Progressive multifocal leukoencephalopathy 30 years later. N Engl J Med 1988;318:315-317
    PubMedWeb of Science
  10. ↵
    Walker DL, Progressive multifocal leukoencephalopathy. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Demyelinating Diseases: Handbook of Clinical Neurology. Amsterdam: Elsevier; 1985; 47:503–524
  11. ↵
    Brooks BR, Walker DL, Progressive multifocal leukoencephalopathy. Neurol Clin 1984;2:299-313
    PubMedWeb of Science
  12. ↵
    Portegies P, Algra PR, Hollak CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337:680-681
    CrossRefPubMedWeb of Science
  13. ↵
    Conway B, Halliday WC, Brunham RC, Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3-azido-3 deoxythymidine. Rev Infect Dis 1990;12:479-482
    PubMed
  14. ↵
    de Truchis P, Flament-Saillour M, Uetizberea J-A, Hassine D, Clair B, Inefficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1993;342:622-623
    PubMed
  15. ↵
    Nicoli F, Chave B, Peragut JC, Gastaut JL, Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1992;306:
  16. Steiger MJ, Tarnesby G, Gable S, McLaughlin J, Schapira AH, Successful outcome of PML with cytarabine and interferon. Ann Neurol 1993;33:407-411
    CrossRefPubMedWeb of Science
  17. Berger JR, Pall L, McArthur JG, et al. A pilot study of recombinant alpha 2A interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy (abstract). Neurology 1992;42(Suppl 3):257
    FREE Full Text
  18. ↵
    Tashiro K, Doi S, Moriwaka F, Maruo Y, Nomura M, Progressive multifocal leukoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 1987;234:427-429
    CrossRefPubMedWeb of Science
  19. ↵
    O'Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD, Progressive multifocal leukoencephalopathy: remission with cytarabine. J Infect 1990;20:51-54
    CrossRefPubMedWeb of Science
  20. Wolinsky JS, Johnson KP, Rand K, Merrigan TC, Progressive multifocal leukoencephalopathy: clinical pathological correlates and failure of a drug trial in two patients. Trans Am Neurol Assoc 1976;101:81-82
    PubMed
  21. Garrels K, Kucharczyk W, Wortzman G, Shandling M, Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 1996;17:597-600
    Abstract
  22. ↵
    Berger JR, Mucke L, Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988;38:1060-1065
    Abstract/FREE Full Text
  23. Fong IW, Toma E, the Canadian PML Study Group The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 1995;20:1305-1310
    CrossRefPubMedWeb of Science
  24. Hedley-White ET, Smith BP, Tyler HR, Peterson WP, Multifocal leukoencephalopathy with remission and five-year survival. J Neuropathol Exp Neurol 1966;25:107-116
    CrossRefWeb of Science
  25. ↵
    Lortholary O, Pialoux G, Dupont B, et al. Prolonged survival of a patient with AIDS and progressive multifocal leukoencephalopathy. Clin Infect Dis 1994;18:826-827
    CrossRefPubMed
  26. Chappel ET, Guthrie BL, Orenstein J, The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992;30:825-829
    CrossRefPubMedWeb of Science
  27. Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S, Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 1995;39:35-44
    PubMed
  28. Levy RM, Rothholtz V, HIV-I-related neurologic disorders: neurosurgical implications in neuroimaging of AIDS II. Neuroimaging Clin N Am 1997;7:527-559
    PubMedWeb of Science
  29. ↵
    Weber T, Turner RW, Frye B, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994;169:1138-1141
    CrossRefPubMedWeb of Science
  30. Moret H, Guichad M, Matherson S, et al. Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993;10:3313
  31. ↵
    McGuire D, Barhite S, Hollander H, et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995;37:395-399
    CrossRefPubMedWeb of Science
  32. ↵
    Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486
    Abstract/FREE Full Text
  33. ↵
    Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by application of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994;8:49-57
    CrossRefPubMedWeb of Science
  34. Brouqui P, Bollet C, Delmont J, Bourgeade A, Diagnosis of progressive multifocal leukoencephalopathy by PCR detection of JC virus from CSF. Lancet 1992;339:1182
  35. ↵
    Major EO, Ault GS, Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995;8:184-190
    CrossRefPubMedWeb of Science
  36. ↵
    Elliott BC, Aromin I, Flanigan TP, Mileno M, Leukoencephalopathy with combined antiretroviral therapy (abstract). Intervent Conf AIDS 1996;11:222
  37. Mileno M, Tashima K, Farrar D, et al. Resolution of AIDS-related opportunistic infections with addition of protease inhibitor treatment (abstract). In: Program and Abstracts of the Fourth Conference on Retrovirus and Opportunistic Infections. Washington, DC: January 22–26, 1997
  38. Huang SS, Skolasky RL, Dal Pan GJ, Royal W, III, McArthur J, Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998;4:324-332
    CrossRefPubMedWeb of Science
  39. Clifford DB, the Neurologic AIDS Research Consortium Natural history of progressive multifocal leukoencephalopathy (PML) in AIDS modified by anti-retroviral therapy (abstract). [Neuroscience of HIV infection. Basic Research and Clinical Frontiers, June 3–6, 1998; Chicago, IL] J Neurovirol 1998;7:346
  40. ↵
    Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, Bryne WR, Hannon RN, Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 1993;161:1049-1051
    PubMedWeb of Science
  41. Guilleux M-H, Steiner RE, Young IR, MR imaging in progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 1986;7:1033-1035
    Abstract/FREE Full Text
  42. ↵
    Mark AS, Atlas SW, Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 1989;173:517-620
    CrossRefPubMedWeb of Science
  43. Olsen WL, Longo FM, Mills CM, Norman D, White matter disease in AIDS: findings at MR imaging. Radiology 1988;169:445-448
    CrossRefPubMedWeb of Science
  44. Ng S, Tse VC, Rubinstein J, Bradford E, Enzmann DR, Conley FK, Progressive multifocal leukoencephalopathy: unusual MR findings. J Comput Assist Tomogr 1995;19:302-305
    PubMedWeb of Science
  45. Newton HB, Makley M, Slivka AP, et al. Progressive multifocal leukoencephalopathy presenting as multiple enhancing lesions on MRI: case report and literature review. J Neuroimaging 1995;5:125-128
    PubMed
  46. Trotot PM, Vazeux R, Yamashita HK, et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. J Neuroradiol 1990;17:233-254
    PubMedWeb of Science
  47. ↵
    Whiteman MLH, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP, Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathogenic correlation. Radiology 1993;187:233-240
    CrossRefPubMedWeb of Science
  48. Balakrishnan J, Becker PS, Kumar AJ, Zinreich SJ, McArthur JC, Bryan RN, Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain. Radiographics 1990;10:201-215
    CrossRefPubMedWeb of Science
  49. Sze G, Brant-Zawadzki MN, Norman D, Newton TH, The neuroradiology of AIDS. Semin Roentgenol 1987;22:42-53
    CrossRefPubMedWeb of Science
  50. Sarrazin JL, Soulie D, Derosier C, Lescop J, Schill H, Cordoliani YS, MRI patterns of progressive multifocal leukoencephalopathy. J Neuroradiol 1995;22:172-179
    PubMed
  51. Lizerbram EK, Hesselink JR, Viral infections. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:261-280
    PubMed
  52. Scatliff JH, Kwock L, Chancellor K, Bouldin TW, Kapoor CC, Castillo M, Postmortem MR imaging of the brains of patients with AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS I) 1997;7:297-320
    PubMed
  53. ↵
    Armand J-D, Dousset V, Viaud B, et al. HIV encephalitis and progressive multifocal leukoencephalopathy: a magnetization transfer study to differentiate pathologic processes. In: Proceedings of the 34th Annual Meeting of the American Society of Neuroradiology, Seattle, 1996. Oak Brook, IL; American Society of Neuroradiology, 1996:27
  54. ↵
    Dousset V, Armand J-P, Huot P, Viaud B, Caille J-M, Magnetization transfer imaging in AIDS-related brain diseases. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:447-460
    PubMed
  55. ↵
    Thurnher MM, Thurnher SA, Fleischmann D, et al. Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol 1997;18:1601-1609
    Abstract
  56. Post MJD, Fluid-attenuated inversion-recovery fast spin-echo MR: a clinically useful tool in the evaluation of neurologically symptomatic HIV-positive patients. AJNR Am J Neuroradiol 1997;18:1611-1616
    PubMedWeb of Science
  57. ↵
    Chang L, Miller B, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:527
  58. Chang L, Ernst T, Tornatore C, et al. Metabolic abnormalities in progressive multifocal leukoencephalopathy: a proton magnetic resonance spectroscopy study. Neurology 1997;48:836-845
    Abstract/FREE Full Text
  59. Chang L, Ernst T, MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:409-426
    PubMed
  60. Miller JR, Barrett RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homosexual with T cell immunodeficiency. N Engl J Med 1982;307:1436-1438
    CrossRefPubMedWeb of Science
  61. Blum LM, Chambers RA, Schwartzman RJ, Streletz LJ, Progressive multifocal leukoencephalopathy in acquired immune deficiency syndrome. Arch Neurol 1985;42:137-139
    CrossRefPubMed
  62. Astrom K-E, Mancall EL, Richardson EP, Jr, Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 1958;81:93-111
    CrossRefPubMedWeb of Science
  63. Zu Rhein GM, Chou S-M, Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965;148:1477-1479
    Abstract/FREE Full Text
  64. Silverman L, Rubinstein LJ, Electron microscopic observation in a case of progressive multifocal leukoencephalopathy. Acta Neuropathol (Berlin) 1965;5:215-224
    CrossRefPubMed
  65. Padgett BL, Walker DL, Zurhein GM, Echroade RJ, Dessel BH, Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1:1251-1260
    PubMed
  66. Bernick C, Gregorios JB, Progressive multifocal leukoencephalopathy in a patient with acquired immunodeficiency syndrome. Arch Neurol 1984;41:780-783
    CrossRefPubMed
  67. Aksamit A, Gendelman H, Orenstein J, Pezeshkpou RG, AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry. Neurology 1990;40:1073-1078
    Abstract/FREE Full Text
  68. Vazeux R, Cumont M, Girard P, et al. Severe encephalitis resulting from co-infection with HIV and JC virus. Neurology 1990;40:944-948
    Abstract/FREE Full Text
  69. Berger JR, Concha M, Progressive multifocal leukoencephalopathy: the evaluation of a disease once considered rare. J Neurovirol 1995;1:5-18
    CrossRefPubMedWeb of Science
  70. Budka H, Neuropathology of myelitis, myelopathy and spinal infections in AIDS. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:639-650
    PubMedWeb of Science
  71. ↵
    Berger JR, Levy RM, Flomenhoft D, Dobbs M, Predictive factors for prolonged survival in AIDS: associated PML. J Neurovirol 1998;4:342
  72. Wright D, Schneider A, Berger JR, Central nervous system opportunistic infections. Neuroimaging Clin N Am (Neuroimaging of AIDS II) 1997;7:513-525
    PubMedWeb of Science
  73. Henry K, Worley J, Sullivan C, et al. Documented improvement in late stage manifestations of AIDS after starting ritonavir in combination with two reverse transcriptase inhibitors (abstract). Opportun Infec 1997; Jan 22;26:130
  74. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1988;338:853-860
    CrossRefPubMedWeb of Science
  75. Esiri M, Kennedy P, Viral diseases. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology. 5th ed. London: Edward Arnsel; 1992:367–370
  76. ↵
    Post MJD, Tate LG, Quencer RM, et al. CT, MR and pathology in HIV encephalitis and meningitis. AJNR Am J Neuroradiol 1988;9:469-476
    Abstract/FREE Full Text
  77. Post MJD, Berger JR, Duncan R, et al. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long term MR imaging and clinical follow-up. Radiology 1993;188:727-733
    CrossRefPubMedWeb of Science
  78. Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA, Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990;175:185-191
    CrossRefPubMedWeb of Science
  79. Post MJD, Sheldon JJ, Hensley GT, et al. Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MRI and pathologic studies. Radiology 1986;158:141-148
    CrossRefPubMedWeb of Science
  80. Ramsey RG, Geremia GK, CNS complications of AIDS: CT and MR findings. AJR Am J Roentgenol 1988;151:449-454
    CrossRefPubMedWeb of Science
  81. Ledoux S, Libman I, Robert F, Just N Progressive multifocal leukoencephalopathy with gray matter involvement. Can J Neurol Sci 1989;16:200-202
    PubMedWeb of Science
  82. Cunningham ME, Kishore PRS, Rengachary SS, Preskorn S, Progressive multifocal leukoencephalopathy presenting as focal mass lesion in the brain. Surg Neurol 1997;8:448-450
  83. Vanneste JAL, Bellot SM, Stam FC, Progressive multifocal leukoencephalopathy presenting as a single mass lesion. Eur Neurol 1984;23:113-118
    CrossRefPubMed
  84. Carroll BA, Lane B, Norman D, Enzmann D, Diagnosis of progressive multifocal leukoencephalopathy by computed tomography. Radiology 1977;122:137-141
    CrossRefPubMedWeb of Science
  85. Tuite M, Keetonen L, Kieburtz K, Handy B, Efficacy of gadolinium in MR brain imaging of HIV-infected patients. AJNR Am J Neuroradiol 1993;14:257-263
    Abstract/FREE Full Text
  86. Heinz ER, Drayer BP, Haeinggell CA, Painter MJ, Crumrine P, Computed tomography in white matter disease. Radiology 1979;130:371-378
    CrossRefPubMedWeb of Science
  87. ↵
    Al-Sahi R, Sadler M, Davies E, Nelson MR, Gazzard BG, Progressive multifocal leukoencephalopathy (PML) treatment with cidofovir. Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva, Switzerland
  88. ↵
    Acosta A, Regression or stabilization of PML by highly active antiretroviral therapy (HAART) and acyclovir therapy. Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva, Switzerland
  89. ↵
    Fichtenbaum CJ, Tantisiviwan W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ, The occurrence of progressive multifocal leukoencephalopathy (PML) in HIV infected persons taking highly active antiretroviral therapy (HAART). Presented at the 12th World AIDS Conference, June 28–July 3, 1998, Geneva Switzerland
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology
Vol. 20, Issue 10
1 Nov 1999
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur, Colin D. Hall
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
American Journal of Neuroradiology Nov 1999, 20 (10) 1896-1906;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
M. Judith Donovan Post, Constantin Yiannoutsos, David Simpson, John Booss, David B. Clifford, Bruce Cohen, Justin C. McArthur, Colin D. Hall
American Journal of Neuroradiology Nov 1999, 20 (10) 1896-1906;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Grey matter abnormality in progressive multifocal leucoencephalopathy
  • Progressive multifocal leukoencephalopathy with hypointense halo on MRI
  • Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS
  • Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES)
  • Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients
  • CNS-Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 1: Overview and Discussion of Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome and Cryptococcal-Immune Reconstitution Inflammatory Syndrome
  • JC Virus Infection of the Brain
  • Use of Diffusion-Weighted Imaging to Evaluate the Initial Response of Progressive Multifocal Leukoencephalopathy to Highly Active Antiretroviral Therapy: Early Experience
  • Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
  • Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Statin Therapy Does Not Affect the Radiographic and Clinical Profile of Patients with TIA and Minor Stroke
  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire